Market Research Logo

North America Drug Discovery Market Forecast 2018-2026

North America Drug Discovery Market Forecast 2018-2026

KEY FINDINGS
The revenue generated by the North American drug discovery market is expected to escalate over the forecast period of 2018-2026, growing at a CAGR of 9.50%.

MARKET INSIGHTS
Growing lifestyle oriented diseases, increase in healthcare spending and technological advancement in cardiology are chiefly driving the demand for North American drug discovery market. More than 90 million Americans carry a diagnosis of CVD. However, US has the world’s finest hospitals and clinics for cardiology surgeries and other heart-related procedures, which is majorly responsible for the country’s dominant share in this market. The Canadian market is also catching up. The country spent approximately $242 billion on health care in 2017, a rise of almost 4% from the previous year.

COMPETITIVE INSIGHTS
Established players in this market include Bayer Ag, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Llc, Pfizer Inc, Boehringer Ingelheim, Eli Lily, AstraZeneca Plc and Merck & Co. Inc.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. High Prevalence Rates Of Major Health Disorders
3.2.2. Implementation Of Drug Discovery Programs
4. Market Determinants
4.1. Market Drivers
4.1.1. Aging Population
4.1.2. Branded Drugs Outperforming Due To High Cost Compared To Generic Drugs
4.1.3. Spending On Healthcare Has Been Increased
4.2. Market Restraints
4.2.1. Government Regulations Delaying The Processes
4.2.2. Delay In Product Launches
4.2.3. Poor Access To The Healthcare Services In Developing Markets
4.2.4. Market Is Shifting From Branded To Generic Drugs
4.3. Market Opportunities
4.3.1. Extensive R & D For New Product Launches
5. Market Segmentation
5.1. Market By Technology 2018-2026
5.1.1. Qpcr
5.1.2. Dna Microarrays
5.1.3. Protein Microarrays
5.1.4. High-throughput Screening
5.1.5. Mass Spectrometry
5.1.6. Gel Electrophoresis
5.1.7. Chromatography
5.1.8. Protein And Nucleic Acid Isolation
5.1.9. Other Technologies
6. Key Analytics
6.1. Porter’s Five Force Analysis
6.1.1. Threats Of New Entrants(Low)
6.1.2. Competitive Rivalry (High)
6.1.3. Bargaining Power Of Buyers (Medium)
6.1.4. Bargaining Power Of Suppliers (Low)
6.1.5. Threat Of Substitute Products (High)
6.2. Value Chain Analysis
6.3. Key Excerpts Of The Study
6.3.1. Relaxation In The Regulations By The Government Which Stops Researchers From Doing Research.
6.3.2. Market Leaders Should Open Up Their Branches And Research Labs In Emerging Markets.
6.4. Pestle Analysis
6.5. Opportunity Matrix
7. Geographical Analysis
7.1. North America
7.1.1. United States (U.S.)
7.1.2. Canada
8. Company Profiles
8.1. Astrazeneca Plc
8.1.1. Company Overview
8.1.2. Product Portfolio
8.1.3. Swot Analysis
8.1.4. Strategic Initiatives
8.2. Bayer Ag
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Swot Analysis
8.2.4. Strategic Initiatives
8.3. Boehringer Ingelheim
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Swot Analysis
8.4. Eli Lily
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Swot Analysis
8.4.4. Strategic Initiatives
8.5. F. Hoffmann-la Roche Ltd
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Swot Analysis
8.5.4. Strategic Initiatives
8.6. Glaxosmithkline Llc
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Swot Analysis
8.6.4. Strategic Initiatives
8.7. Johnson And Johnson
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Swot Analysis
8.7.4. Strategic Initiatives
8.8. Merck & Co. Inc.
8.8.1. Company Overview
8.8.2. Product Portfolio
8.8.3. Swot Analysis
8.8.4. Strategic Initiatives
8.9. Pfizer, Inc.
8.9.1. Company Overview
8.9.2. Swot Analysis
8.9.3. Strategic Initiatives
8.10. Sanofi
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Swot Analysis
8.10.4. Strategic Initiatives
Table List
Table 1 North America Drug Discovery Market 2018-2026 (In $million)
Table 2 North America Drug Discovery Market, By Technology 2018-2026
Table 3 North America Drug Discovery Market In Qpcr 2018-2026 (In $million)
Table 4 North America Drug Discovery Market In Dna Microarrays 2018-2026 (In $million)
Table 5 North America Drug Discovery Market In Protein Microarrays, 2018-2026(In $million)
Table 6 North America Drug Discovery Market In High Throughput Screening, 2018-2026(In $million)
Table 7 North America Drug Discovery Market In Mass Spectrometry, 2018-2026(In $million)
Table 8 North America Drug Discovery Market In Gel Electrophoresis, 2018-2026, (In $million)
Table 9 North America Drug Discovery Market In Chromatography, 2018-2026 (In $million)
Table 10 North America Drug Discovery Market In Protein And Nucleic Acid Isolation, 2018-2026 (In $million)
Table 11 North America Drug Discovery Market In Other Technologies Market, 2018-2026 (In $million)
Table 12 North America Drug Discovery Market, 2018-2026 (In $million)
Table 13 North America Drug Discovery Market, 2018-2026 (In $ Million)
Figure List
Figure 1 North America Drug Discovery Market 2018-2026 (In $million)
Figure 2 North America Drug Discovery Market In Qpcr 2018-2026 (In $million)
Figure 3 North America Drug Discovery Market In Dna Microarrays 2018-2026 (In $million)
Figure 4 North America Drug Discovery Market In Protein Microarrays 2018-2026 (In $million)
Figure 5 North America Drug Discovery Market In High Throughput Screening 2018-2026 (In $million)
Figure 6 North America Drug Discovery Market In Mass Spectrometry 2018-2026 (In $million)
Figure 7 North America Drug Discovery Market In Gel Electrophoresis 2018-2026 (In $million)
Figure 8 North America Drug Discovery Market In Chromatography 2018-2026 (In $million)
Figure 9 North America Drug Discovery Market In Protein And Nucleic Acid Isolation 2018-2026 (In $million)
Figure 10 North America Drug Discovery Market In Other Technologies 2018-2026 (In $million)
Figure 11 North America Drug Discovery Market, 2018-2026 (In $million)
Figure 12 North America Drug Discovery Market, 2018-2026 (In $ Million)
Figure 13 United States Drug Discovery Market, 2018-2026 (In $ Million)
Figure 14 Canada Drug Discovery Market, 2018-2026 (In $million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report